Search

Search Constraints

You searched for: Author/Creator Takeshima, Fuminao

Search Results

1. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. (July 2022)

2. Clinical efficacy of adalimumab in Crohn's disease: a real practice observational study in Japan. Issue 1 (December 2016)

3. Effect of a concomitant elemental diet with maintenance anti‐tumor necrosis factor‐α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study. Issue 1 (16th July 2018)

4. Endocytoscopic classification can be predictive for relapse in ulcerative colitis. Issue 10 (March 2018)

5. Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. (19th October 2015)

6. Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. (19th October 2015)

7. Increased expression of vascular endothelial growth factor in a case of protein‐losing enteropathy with undifferentiated connective tissue disease. (5th June 2014)

9. Magnifying Endoscopic Findings Can Predict Clinical Outcome during Long-Term Follow-Up of More Than 12 Months in Patients with Ulcerative Colitis. (2nd October 2013)